OBJECTIVE: Clinicians monitor cognitive effects of drugs primarily by asking patients to describe their side effects. We examined the relationship of subjective perception of cognition to mood and objective cognitive performance in healthy volunteers and neurological patients. METHODS: Three separate experiments used healthy adults treated withlamotrigine (LTG) and topiramate (TPM), adults with epilepsy on LTG or TPM, and patients with idiopathic Parkinson's disease. Correlations were calculated for change scores on and off drugs in the first two experiments and for the single assessment in Experiment 3. RESULTS: Across all three experiments, significant correlations were more frequent (chi(2)=259, P < or = 0.000) for mood versus subjective cognitive perception (59%) compared with subjective versus objective cognition (2%) and mood versus objective cognitive performance (2%). CONCLUSIONS:Subjective perception of cognitive effects is related more to mood than objective performance. Clinicians should be aware of this relationship when assessing patients' cognitive complaints.
RCT Entities:
OBJECTIVE: Clinicians monitor cognitive effects of drugs primarily by asking patients to describe their side effects. We examined the relationship of subjective perception of cognition to mood and objective cognitive performance in healthy volunteers and neurological patients. METHODS: Three separate experiments used healthy adults treated with lamotrigine (LTG) and topiramate (TPM), adults with epilepsy on LTG or TPM, and patients with idiopathic Parkinson's disease. Correlations were calculated for change scores on and off drugs in the first two experiments and for the single assessment in Experiment 3. RESULTS: Across all three experiments, significant correlations were more frequent (chi(2)=259, P < or = 0.000) for mood versus subjective cognitive perception (59%) compared with subjective versus objective cognition (2%) and mood versus objective cognitive performance (2%). CONCLUSIONS: Subjective perception of cognitive effects is related more to mood than objective performance. Clinicians should be aware of this relationship when assessing patients' cognitive complaints.
Authors: R Schmidt; W Freidl; F Fazekas; B Reinhart; P Grieshofer; M Koch; B Eber; M Schumacher; K Polmin; H Lechner Journal: Neurology Date: 1994-05 Impact factor: 9.910
Authors: Mani N Pavuluri; David B Henry; Julie A Carbray; Gwen A Sampson; Michael W Naylor; Philip G Janicak Journal: J Child Adolesc Psychopharmacol Date: 2006-06 Impact factor: 2.576
Authors: Julio Sanjuán; Eduardo-Jesus Aguilar; Jose Manuel Olivares; Salvador Ros; Angel Luis Montejo; Fermin Mayoral; Miguel Angel Gonzalez-Torres; Manuel Bousoño Journal: J Nerv Ment Dis Date: 2006-01 Impact factor: 2.254
Authors: S G Uijl; C S M P Uiterwaal; A P Aldenkamp; J A Carpay; J C Doelman; K Keizer; C J Vecht; M C de Krom; C A van Donselaar Journal: Seizure Date: 2006-03-23 Impact factor: 3.184
Authors: K J Meador; A Gevins; D W Loring; L K McEvoy; P G Ray; M E Smith; G K Motamedi; B M Evans; C Baum Journal: Neurology Date: 2007-11-27 Impact factor: 9.910
Authors: Jacob D Jones; Chris Hass; Paul Mangal; Jacob Lafo; Michael S Okun; Dawn Bowers Journal: Parkinsonism Relat Disord Date: 2014-09-18 Impact factor: 4.891
Authors: Robert J Quon; Morgan T Mazanec; Samantha S Schmidt; Angeline S Andrew; Robert M Roth; Todd A MacKenzie; Martha Sajatovic; Tanya Spruill; Barbara C Jobst Journal: Epilepsy Behav Date: 2020-01-29 Impact factor: 2.937
Authors: Denise D Correa; Maria Kryza-Lacombe; Raymond E Baser; Kathryn Beal; Lisa M DeAngelis Journal: J Neurooncol Date: 2016-01-06 Impact factor: 4.130